Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Doxycycline pellets: a suitable formulation with guaranteed bioequivalence]

B Hampel, H Lode, H Fenner

    Arzneimittel-Forschung
    |January 1, 1980
    PubMed
    Summary

    A new doxycycline pellet formulation shows improved gastric tolerance and comparable bioavailability to existing forms. Pharmacokinetic simulations confirm sustained therapeutic drug levels, reducing oesophageal irritation risk.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Measurement setup for the characterization of integrated semiconductor circuits at cryogenic temperatures.

    The Review of scientific instruments·2025
    Same author

    Active impedance matching of a cryogenic radio frequency resonator for ion traps.

    The Review of scientific instruments·2022
    Same author

    THz microscope for three-dimensional imaging with superconducting Josephson junctions.

    The Review of scientific instruments·2022
    Same author

    Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection.

    HIV medicine·2021
    Same author

    Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017.

    HIV medicine·2019
    Same author

    Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland.

    HIV medicine·2018

    Area of Science:

    • Pharmacology
    • Pharmaceutics
    • Drug Delivery Systems

    Background:

    • Doxycycline is a widely used antibiotic with administration challenges.
    • Optimizing doxycycline delivery can improve patient compliance and therapeutic outcomes.

    Purpose of the Study:

    • To develop and evaluate a novel doxycycline pellet formulation.
    • To assess the bioavailability and tolerability of the new formulation compared to a standard product.

    Main Methods:

    • Cross-over study design in normal subjects.
    • Evaluation of drug liberation profile, gastric tolerance, and plasma pharmacokinetic parameters (AUC, peak levels).
    • Pharmacokinetic computer simulation for multiple-dose treatment.

    Main Results:

    Related Experiment Videos

    • The new pellet formulation demonstrated significantly better gastric tolerance.
    • No significant differences in plasma AUC indicated bioequivalence between formulations.
    • Drug liberation profile minimized oesophageal irritation risk.
    • Simulations showed therapeutic doxycycline plasma levels maintained above the Minimum Inhibitory Concentration (MIC) during multiple dosing.

    Conclusions:

    • The novel doxycycline pellet formulation is bioequivalent and better tolerated than the comparative product.
    • This formulation offers a safer administration profile, reducing risks of oesophageal and gastric irritation.
    • The pellet formulation ensures sustained therapeutic drug concentrations, supporting effective antibiotic treatment.